Clinical Trial

Hepatic Safety of Statin Use in Neurology Inpatients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated October 10, 2024 completion). Its status may not reflect the trial's current state.
Summary
This research employs a cross-sectional study and a retrospective cohort study to analyze the liver safety of statin use among inpatients in the neurology department in China from different perspectives. The aim is to supplement evidence-based medicine and provide guidance for the clinical use of statins.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-04.
Trial Details
NCT Number NCT06592196
Lead Sponsor Shanghai Yueyang Integrated Medicine Hospital
Conditions Statin Adverse Reaction
Enrollment 2,000 participants
Start Date 2024-08-10
Primary Completion 2024-10-10 (estimated)
Study Completion 2024-12-10 (estimated)
Updated on ClinicalTrials.gov 2024-09-19